Table 3.
Participant characteristics (N=18)
Characteristic | Mean (SD) or N (%) | ||
Age (years) | 71.5 (5.3) | ||
Sex (female) | 10 (56%) | ||
Ethnicity | Hispanic or Latino | 9 (50%) | |
Not Hispanic or Latino | 9 (50%) | ||
T2D duration (years, SD) | 14.4 (9.4) | ||
T2D Treatment (%) | Oral agents | 12 (66%) | |
Insulin | 3 (17%) | ||
Combination of oral agents and insulin | 3 (17%) | ||
Frailty Characteristics at baseline (Yes, %) | Frailty Characteristics at 6-months (Yes, %) | ||
Slowness | 4 (22%) | Slowness | 2 (11%) |
Weakness | 9 (50%) | Weakness | 5 (27%) |
Weight loss | 3 (17%) | Weight loss | 0 |
Exhaustion | 9 (50%) | Exhaustion | 6 (33%) |
Physical activity | 4 (22%) | Low physical activity | 3 (17%) |
Frailty status at baseline | Frailty status at 6-months | ||
Pre-Frail | 13 (72%) | Pre-Frail | 9 (50%) |
Frail | 4 (22%) | Frail | 2 (11%) |
Non-Frail | 1 (6%) | Non-Frail | 7 (39%) |